NCT01541618View on ClinicalTrials.gov

A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
OTHER

MSDX Complex-1 Biomarker test

MSDX Complex-1 Biomarker test

Trial Locations (1)

85741

Northwest NeuroSpecialists, PLLC, Tucson

All Listed Sponsors
lead

MSDx, Inc.

INDUSTRY

NCT01541618 - A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis | Biotech Hunter | Biotech Hunter